A Study to Evaluate the Effects of ABX-1431 on Patients With Tourette Syndrome
Clinical trial NCT03058562 · COMPLETED
Trial details
- NCT number
- NCT03058562
- Sponsor
- Abide Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-01
- Primary completion
- 2017-10-04
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.